Mindfulness techniques to help hematologic cancer patients manage sleep issues during and after hospital treatment
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
This study is testing a friendly online program called Nite2Day+ to help patients with blood cancers who have trouble sleeping while in the hospital, teaching them relaxation techniques to improve their sleep and feel better overall.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10982416 on NIH RePORTER |
What this research studies
This research focuses on helping patients with hematologic cancers who struggle with insomnia and related symptoms during and after their hospital treatment. It involves a 6-session, therapist-led telehealth intervention called Nite2Day+, which teaches mindfulness meditations and behavioral strategies to improve sleep quality and reduce fatigue, distress, and pain. The intervention will be adapted for use in the hospital setting and delivered through a mobile app, allowing patients to engage with the material at their own pace. The study aims to assess how well this approach works in improving sleep and overall well-being for patients during their inpatient stay.
Who could benefit from this research
Good fit: Ideal candidates for this research are hematologic cancer patients experiencing insomnia symptoms while hospitalized for treatment.
Not a fit: Patients who do not have hematologic cancers or those who are not currently experiencing sleep disturbances may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve sleep quality and reduce distress for hematologic cancer patients during their hospital stay.
How similar studies have performed: Previous research has shown promising results with mindfulness interventions for symptom management in cancer patients, indicating potential for success with this adapted approach.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Fisher, Hannah M — Duke University
- Study coordinator: Fisher, Hannah M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.